TRUE · As filed with the SEC
TrueCar balance sheet, by fiscal year
The statement as TrueCar presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD thousands
| USD thousands | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | FY2021 Dec 31, 2021 |
|---|---|---|---|---|
| Assets | ||||
| Current assets | ||||
| Cash and cash equivalents (includes restricted cash of $0 and $1,855 at December 31, 2024 and 2023, respectively) | 111,835 | 136,964 | 175,518 | 245,217 |
| Accounts receivable, net of allowances of $783 and $1,118 at December 31, 2024 and 2023, respectively | 15,742 | 18,264 | 13,786 | 16,710 |
| Prepaid expenses | 4,499 | 6,067 | 5,969 | 6,145 |
| Other current assets | 3,052 | 1,787 | 2,562 | 1,866 |
| Total current assets | 135,128 | 163,082 | 197,835 | 269,938 |
| Property and equipment, net | 15,735 | 18,880 | 18,902 | 19,155 |
| Operating lease right-of-use assets | 2,351 | 10,132 | 16,940 | 23,605 |
| Goodwill | — | — | 0 | 51,205 |
| Intangible assets, net | 1,970 | 8,375 | 13,969 | 4,950 |
| Equity method investment | — | — | 0 | 14,500 |
| Other assets | 4,507 | 3,851 | 3,881 | 4,317 |
| Total assets | 159,691 | 204,320 | 251,527 | 387,670 |
| Liabilities and Stockholders’ Equity | ||||
| Current liabilities | ||||
| Accounts payable | 7,928 | 6,875 | 8,655 | 11,364 |
| Accrued employee expenses | 4,892 | 6,667 | 7,378 | 5,187 |
| Operating lease liabilities, current | 2,964 | 3,240 | 4,514 | 5,253 |
| Accrued expenses and other current liabilities | 17,109 | 12,196 | 10,232 | 9,677 |
| Total current liabilities | 32,893 | 28,978 | 30,779 | 31,481 |
| Deferred tax liabilities | — | — | 0 | 103 |
| Operating lease liabilities, net of current portion | 8,313 | 11,169 | 18,500 | 26,300 |
| Other liabilities | 348 | 3,958 | 4,981 | 0 |
| Total liabilities | 41,554 | 44,105 | 54,260 | 57,884 |
| Stockholders’ Equity | ||||
| Preferred stock — $0.0001 par value; 20,000,000 shares authorized at December 31, 2024 and 2023, respectively; no shares issued and outstanding at December 31, 2024 and 2023 | 0 | 0 | 0 | 0 |
| Common stock — $0.0001 par value; 1,000,000,000 shares authorized at December 31, 2024 and 2023; 87,190,136 and 91,091,541 shares issued and outstanding at December 31, 2024 and 2023, respectively | 9 | 9 | 9 | 10 |
| Additional paid-in capital | 711,474 | 722,504 | 709,790 | 723,623 |
| Accumulated deficit | (593,346) | (562,298) | (512,532) | (393,847) |
| Total stockholders’ equity | 118,137 | 160,215 | 197,267 | 329,786 |
| Total liabilities and stockholders’ equity | 159,691 | 204,320 | 251,527 | 387,670 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
